rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Natco Pharma Ltd.

524816 NATCOPHARM Group (A)

22 Jul,14:31
1224.30
0.20 (0.02%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Natco Pharma Ltd.

BUYSELL
75,992 1,224.10 1,253.35 - 1,207.45 1,311.00 - 714.65 21,927.22
NSE | BSE

Natco Pharma Ltd.

NATCOPHARM

22 Jul,14:31
1224.95
1.60 (0.13%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Natco Pharma Ltd.

BUYSELL
585,239 1223.35 1,254.00 - 1,209.10 1,311.00 - 716.95 7,208.21

News for Natco Pharma Ltd.

USFDA Warns Natco...
USFDA Warns Natco Pharma for Manufacturing Lapses
USFDA issued a warning letter to Natco Pharma for violations at its Telangana plant, citing cleanliness, sterilization, and contamination concerns. The regulator has asked for a comprehensive...
Apr 21, 2024 10:45
Natco Pharma...
Natco Pharma Faces US Lawsuit Over Diazepam Injection
Fresenius Kabi has filed a complaint against Natco Pharma in a US district court over the marketing of Diazepam injection prefilled syringes. Natco Pharma plans to defend the lawsuit.
Apr 18, 2024 10:55
Natco Pharma Gets...
Natco Pharma Gets USFDA Warning Letter for Telangana Plant
Natco Pharma received a warning letter from the USFDA for its Telangana plant due to violations found during an inspection. The company assures minimal impact on supplies and revenues but...
Apr 09, 2024 10:51
Natco Pharma Q3 Profit Soars 300% to Rs 212.7 Cr
Natco Pharma's net profit surged over 300% to Rs 212.7 crore in Q3 FY24 driven by strong revenue growth. Read more about the company's performance.
Feb 14, 2024 14:51
Natco Pharma...
Natco Pharma Anti-trust Lawsuit Dismissed in US
Natco Pharma has had anti-trust claims against it regarding a generic cancer treatment drug in the US dismissed. The lawsuit was filed by Louisiana Health Service & Indemnity Company.
Dec 21, 2023 18:24

More News for Natco Pharma Ltd. »

(Rs. Crore)

Financial Results of Natco Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,568.902,351.001,767.801,653.501,790.20
Operating profit1,637.00844.70213.00417.60578.00
Interest14.508.6013.3011.3020.60
Gross profit1,727.20921.60294.30507.40681.20
EPS (Rs)72.9934.917.6216.9626.07

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Natco Pharma Ltd.

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US. Wikipedia

News for Pharmaceuticals and health care

Clean Coal...
Clean Coal Initiatives: Eco Survey Urges Promotion
India's Economic Survey emphasizes promoting cleaner coal technologies like gasification and coal-to-hydrogen to reduce emissions and achieve energy security.
Jul 22, 2024 14:20
Real Estate...
Real Estate Outlook Encouraging: Economic Survey
India's Economic Survey forecasts a positive outlook for the real estate sector driven by urbanization and rising housing demand, but highlights stalled projects as a challenge.
Jul 22, 2024 14:19
Green Steel: Key...
Green Steel: Key to Low Carbon Economy - Economic Survey
India's Economic Survey highlights the crucial role of green steel in the global shift to a low-carbon economy. Explore the challenges and opportunities for India's steel sector.
Jul 22, 2024 14:16
India Tourism Job...
India Tourism Job Creation: Economic Survey Highlights Potential
India's tourism sector presents a prime opportunity for job creation, says the Economic Survey, citing growth in tourist arrivals and hotel supply. The survey emphasizes the need for skilled...
Jul 22, 2024 14:03
Farm Policy...
Farm Policy Re-orientation: CEA Nageswaran's Call
CEA Nageswaran advocates for a pan-India dialogue on agriculture, urging policy re-orientation despite subsidies, to address challenges like soil degradation and environmental pollution.
Jul 22, 2024 13:56

More News »

Top News

India: GCC Hub for Global Cos - Economic Survey
India emerges as a global favorite for Global Capability Centers (GCCs), with the government playing a crucial role in facilitating their entry. The Economic Survey highlights the country's talent...
Jul 22, 2024 14:22
Clean Coal...
Clean Coal Initiatives: Eco Survey Urges Promotion
India's Economic Survey emphasizes promoting cleaner coal technologies like gasification and coal-to-hydrogen to reduce emissions and achieve energy security.
Jul 22, 2024 14:20
Real Estate...
Real Estate Outlook Encouraging: Economic Survey
India's Economic Survey forecasts a positive outlook for the real estate sector driven by urbanization and rising housing demand, but highlights stalled projects as a challenge.
Jul 22, 2024 14:19
Green Steel: Key...
Green Steel: Key to Low Carbon Economy - Economic Survey
India's Economic Survey highlights the crucial role of green steel in the global shift to a low-carbon economy. Explore the challenges and opportunities for India's steel sector.
Jul 22, 2024 14:16
India Tourism Job...
India Tourism Job Creation: Economic Survey Highlights Potential
India's tourism sector presents a prime opportunity for job creation, says the Economic Survey, citing growth in tourist arrivals and hotel supply. The survey emphasizes the need for skilled...
Jul 22, 2024 14:03

More Top News »

Report Card

PE Ratios
16.77
EPS (Rs.)
72.99
Sales (Rs. Cr)
964.80
Face Value (Rs.)
2
Net Profit Margin (%)
27.09
Last Bonus
Last Dividend(%)
62.5
Return on Average Equity
13.54

BSE Announcements from Natco Pharma Ltd. (See all)

announcement Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 4 day(s) ago
announcement Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 08 Jul 2024

Compare 'Natco Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

I am 32 years and I have one daughter who is 2 year...

i am a retired PSU employee and in FY 2324, have...

I am 40 years old.I am earning monthly salary of...

I have taken early retirement due to my health...

Hi, I want to understand about SWP mutual fund...

Hi, I am employed in Maldives from last one year and...

More REDIFFGURUS

RediffGurus

Money question

I am 50 year old retired person.I have fd of 2 cr...

Natco Pharma Ltd. performance snapshot

If you had invested Rs.  in Natco Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Natco Pharma Ltd.
Share Price » Fundamentals » Financial » Technicals » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Natco Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Natco Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close